Ron shares his groundbreaking discoveries about the various forms of LDL, emphasizing the distinction between small and very small LDL particles. He highlights the genetic associations of these particles with risk and discusses ongoing research aimed at understanding their secretion mechanisms. The conversation hints at the challenges of lowering these particles, drawing parallels to LP little A, a genetic factor that remains elusive in treatment.
